Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
2024-0013-RCOC
Approved small_molecule active
Quick answer
Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321) for Diabetic Macular Edema (DME) is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Diabetic Macular Edema (DME)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active